SCHEMBL5266758

SCHEMBL5266758

C#C[Si](C)(C)C[Si](C)(C)C#C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2194987 0.75
SCHEMBL1275932 0.72
SCHEMBL698327 0.69
SCHEMBL4699 0.67
SCHEMBL2885270 0.67
SCHEMBL2082322 0.67
SCHEMBL1332124 0.67
SCHEMBL10731186 0.67
SCHEMBL19600557 0.65
SCHEMBL4948983 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648906-B1 ORGANOSILICON COMPOUNDS AND THEIR USE TAKEDA CAMBRIDGE LTD (GB) 2007-10-03 EP disclosed
US-20070111967-A1 Organosilicon compounds and their use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-05-17 US disclosed
US-20070111967-A1 Organosilicon compounds and their use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-05-17 US disclosed
EP-1648906-A1 ORGANOSILICON COMPOUNDS AND THEIR USE Paradigm Therapeutics Limited (GB) 2006-04-26 EP disclosed
WO-2005005443-A1 ORGANOSILICON COMPOUNDS AND THEIR USE PARADIGM THERAPEUTICS LTD. (GB) 2005-01-20 WO disclosed